Diagnostic Imaging Equipment Market Segmentation:
Product Segment Analysis
In terms of product, the MRI systems sub-segment is predicted to hold a dominant revenue share of 28.5% in the diagnostic imaging equipment market over the assessed timeline. The leadership is primarily attributable to the increasing neurological and musculoskeletal disorders worldwide. Testifying to the same, the WHO expected the number of people across the globe suffering from dementia to surpass 80.4 million by the end of 2030. This demography is garnering substantial need for advanced neuroimaging technologies. Furthermore, recent updates in reimbursement policies, such as the 2023 coverage expansion of Medicare for Alzheimer's diagnostic imaging, are remarkably enhancing patient access to critical neurological assessments, including MRI technology.
Application Segment Analysis
Based on applications, the oncology segment is poised to command a leading share of 32.4% in the diagnostic imaging equipment market by the end of 2034. With a 40.3% surge in global cancer incidence in 2024 alone, this medical discipline underscores the critical need for early detection solutions. The segment's expansion is also escalated by regulatory support, particularly the FDA's 510(k) fast-track pathway for AI-powered tumor detection tools, which is streamlining the adoption of advanced technologies in this category. Moreover, the rising cancer prevalence and capital-backed innovations are cumulatively attracting more investment in precision oncology imaging systems from both public and private organizations.
Our in-depth analysis of the global diagnostic imaging equipment market includes the following segments:
|
Segment |
Subsegment |
|
Product |
|
|
Application |
|
|
End user |
|
